CymitQuimica logo

CAS 1255517-76-0

:

PF-4708671

Description:
PF-4708671, with the CAS number 1255517-76-0, is a small molecule that serves as a selective inhibitor of the protein kinase mTOR (mechanistic target of rapamycin). This compound is primarily investigated for its potential therapeutic applications in cancer treatment and other diseases characterized by dysregulated mTOR signaling. PF-4708671 exhibits a high degree of specificity for mTOR, which is a central regulator of cell growth, proliferation, and survival. The inhibition of mTOR by PF-4708671 can lead to reduced protein synthesis and cell cycle arrest, making it a candidate for combination therapies in oncology. Additionally, the compound has been studied for its effects on metabolic processes and its potential role in addressing conditions such as obesity and diabetes. As with many investigational drugs, the pharmacokinetics, bioavailability, and safety profile of PF-4708671 are subjects of ongoing research to better understand its efficacy and potential side effects in clinical settings.
Formula:C19H21F3N6
Synonyms:
  • 1H-Benzimidazole, 2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-
  • 2-[[4-(5-Ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-1H-benzimidazole PF-4708671
  • CS-869
  • PF-4708671 USP/EP/BP
  • PF 4708671
  • PF 4708671 - PF 04708671
  • 2-[[4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-5-(trifluoromethyl)-1H-benzo[d]imidazole
  • PF4708671/PF-4708671
  • PF-04708671
  • 2-[[4-(5-ethyl-4-pyriMidinyl)-1-piperazinyl]Methyl]-6-(trifluoroMethyl)-1H-benziMidazole
  • 2-[[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-6-(trifluoromethyl)-1H-benzimidazole
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.